Big Pharma are investing huge amounts in data analytics, but what are the challenges and opportunities of using data? – Infographic: 2019 Latest Industry Trends Read more
Novartis stands behind Zolgensma (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy Read more
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial Read more
Sanofi : Dupixent (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis Read more